2seventy bio, Inc. (TSVT) Tops Q3 EPS by 36c

2seventy bio, Inc. (NASDAQ: TSVT) reported Q3 EPS of ($1.40), $0.36 better than the analyst estimate of ($1.76). Revenue for the quarter came in at $12 million versus the consensus estimate of $13.4 million.

For earnings history and earnings-related data on 2seventy bio, Inc. (TSVT) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Four Tree Island Advisory calls DoubleDown $11.25 offer too low
• Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance